NPR2

Chr 9ARAD

natriuretic peptide receptor 2

Also known as: AMD1, AMDM, ANPRB, ANPb, ECDM, GC-B, GCB, GUC2B

This gene encodes natriuretic peptide receptor B, one of two integral membrane receptors for natriuretic peptides. Both NPR1 and NPR2 contain five functional domains: an extracellular ligand-binding domain, a single membrane-spanning region, and intracellularly a protein kinase homology domain, a helical hinge region involved in oligomerization, and a carboxyl-terminal guanylyl cyclase catalytic domain. The protein is the primary receptor for C-type natriuretic peptide (CNP), which upon ligand binding exhibits greatly increased guanylyl cyclase activity. Mutations in this gene are the cause of acromesomelic dysplasia Maroteaux type. [provided by RefSeq, Jul 2008]

Primary Disease Associations & Inheritance

Acromesomelic dysplasia 1, Maroteaux typeMIM #602875
AR
Epiphyseal chondrodysplasia, Miura typeMIM #615923
AD
Short stature with nonspecific skeletal abnormalitiesMIM #616255
AD
828
ClinVar variants
58
Pathogenic / LP
0.00
pLI score
0
Active trials
Clinical SummaryNPR2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.33) despite low pLI — interpret in context.
📋
ClinVar Variants
58 Pathogenic / Likely Pathogenic· 306 VUS of 828 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.49LOEUF
pLI 0.000
Z-score 4.54
OE 0.33 (0.230.49)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
2.96Z-score
OE missense 0.66 (0.610.72)
398 obs / 602.3 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.33 (0.230.49)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.66 (0.610.72)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.96
01.21.6
LoF obs/exp: 18 / 54.0Missense obs/exp: 398 / 602.3Syn Z: 0.46

ClinVar Variant Classifications

828 submitted variants in ClinVar

Classification Summary

Pathogenic38
Likely Pathogenic20
VUS306
Likely Benign100
Benign13
Conflicting9
38
Pathogenic
20
Likely Pathogenic
306
VUS
100
Likely Benign
13
Benign
9
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
12
2
24
0
38
Likely Pathogenic
11
2
7
0
20
VUS
0
285
17
4
306
Likely Benign
0
1
42
57
100
Benign
0
0
12
1
13
Conflicting
9
Total2329010262486

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NPR2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

NPR2-related acromesomelic dysplasia Maroteaux type

definitive
ARLoss Of FunctionAbsent Gene Product
Dev. DisordersSkinSkeletal
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Acromesomelic dysplasia 1, Maroteaux type

MIM #602875

Molecular basis of disorder known

Autosomal recessive

Epiphyseal chondrodysplasia, Miura type

MIM #615923

Molecular basis of disorder known

Autosomal dominant

Short stature with nonspecific skeletal abnormalities

MIM #616255

Molecular basis of disorder known

Autosomal dominant
Clinical Literature
Landmark / reviewRecent case evidence
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →